Sang Won Shin, MD

Articles by Sang Won Shin, MD

Oral UFT and Leucovorin in Patients With Advanced Gastric Carcinoma

ByYeul Hong Kim, MD,Sang Won Shin, MD,Byung Soo Kim, MD,Young Tae Park, MD,Jongguk Kim, MD,Jun Suk Kim, MD

September 2nd 1997

Thirty-nine patients with locally advanced or metastatic gastric carcinoma received oral UFT (tegafur and uracil) plus leucovorin. Treatment consisted of UFT 360 mg/m2/day plus leucovorin 25 mg/m2/day, given orally in divided

Latest Updated Articles

Oral UFT and Leucovorin in Patients With Advanced Gastric Carcinoma
September 2nd 1997

Trending on CancerNetwork

Novel HP1K Inhibitor Shows Favorable Responses in ccRCC, Solid Tumors

FDA Grants RMAT Designation to RZ-001 in Advanced Hepatocellular Carcinoma

MYTHIC Trial Demonstrates Efficacy in Platinum-Resistant Ovarian Cancer

119 Progression-Free Survival (PFS) and Overall Survival (OS) Results From the Phase 3 MONALEESA-3 Trial of Postmenopausal Patients With Hormone Receptor–Positive (HR+)/Human Epidermal Growth Factor Receptor 2–Negative (HER2−) Advanced Breast Cancer (ABC) Treated With Ribociclib (RIB) + Fulvestrant (FUL): A Subgroup Analysis of Patients With Invasive Lobular Carcinoma (ILC)